Share

    


In This Section

Colorectal Cancer

Colorectal cancer represents 8.3 percent of all new cancer diagnoses in the U.S. In 2016, there were an estimated 1,324,922 people in the U.S. living with colorectal cancer. It is the second-leading cause of cancer death in the U.S., accounting for 8.4 percent of all cancer deaths.

The rate of new colorectal cancer cases has been falling an average of 2.4 percent each year over the last 10 years. Death rates fell an average of 2.2 percent each year between 2007 and 2016. Depending on whether and how much the cancer has spread, colorectal cancer is most often treated with radiation, chemotherapy, or surgery.

Source: NIH National Cancer Institute, Cancer Stat Facts: Colorectal Cancer

Biomarker Testing in Personalized Treatment Selection for Metastatic Colorectal Cancer

To support quality improvement (QI) projects in mCRC (metastatic colorectal cancer), the Association of Community Cancer Centers (ACCC) has partnered with Pfizer Global Medical Grants to award $1.5 million in funding for QI projects that are aimed at improving the integration of biomarker testing in personalized treatment selection for patients with mCRC.

Learn More
Collaboration of Multidisciplines for Biomarker Testing Implementation Needed for Effective Treatment Decisions in mCRC

The goal of this initiative is to provide guidance for multidisciplinary care teams on how to develop practical biomarker testing protocols for metastatic colorectal cancer and how this information can support personalized treatment decisions for improved patient outcomes.

Learn More

From the ACCC Buzz Blog

  • colorectal-cancer-awareness-240x160
    ACCC Recognizes National Colorectal Cancer Awareness Month
    March 30, 2022
    The US has seen a steady decline in the overall incidence of colorectal cancer (CRC) during the past several decades. In 1975, 60 people per 100,000 were diagnosed with colorectal cancer; by 2018, that number had fallen to 34. But overall trends in CRC incidence and outcomes often differ among racial groups and geographic locations. Black Americans are more likely to be diagnosed with CRC than White Americans and more likely to die from it. CRC mortality rates in American Indian and Alaska Native populations have stubbornly stayed put.
  • Aware-for-All-1-
    ACCC Recognizes Colorectal Cancer Awareness Month With RFP
    March 24, 2021
    To help address the ongoing prevalence of colorectal cancer, ACCC is inviting its members to submit proposals for quality improvement initiatives in treating metastatic forms of this cancer.
  • Lessons Learned From Cancer Patients
    April 07, 2020

News & Media

Association of Community Cancer Centers and Pfizer Award $600,000 in Funding for Quality Improvement in Integration of Biomarker Testing into Personalized Treatment Selection for Colorectal Cancer
Oct 25, 2021